chr17-4167856-T-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001330063.2(ANKFY1):āc.3433A>Gā(p.Ile1145Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001330063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKFY1 | NM_001330063.2 | c.3433A>G | p.Ile1145Val | missense_variant | 25/25 | ENST00000341657.9 | NP_001316992.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKFY1 | ENST00000341657.9 | c.3433A>G | p.Ile1145Val | missense_variant | 25/25 | 5 | NM_001330063.2 | ENSP00000343362 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249476Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135360
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461770Hom.: 0 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 727196
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.3436A>G (p.I1146V) alteration is located in exon 25 (coding exon 25) of the ANKFY1 gene. This alteration results from a A to G substitution at nucleotide position 3436, causing the isoleucine (I) at amino acid position 1146 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at